| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BMCL.2007.03.003 |
| P698 | PubMed publication ID | 17368897 |
| P50 | author | Karen J Shaw | Q56999092 |
| P2093 | author name string | Ronald Wolin | |
| John J M Wiener | |||
| Michael D Hack | |||
| Todd K Jones | |||
| Jiejun Wu | |||
| Brian J Morrow | |||
| Cheryl A Grice | |||
| S Timothy Motley | |||
| Laurent Gomez | |||
| Hari Venkatesan | |||
| Alejandro Santillán | |||
| Daniel J Pippel | |||
| Neelakandha Mani | |||
| P433 | issue | 10 | |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 2723-2727 | |
| P577 | publication date | 2007-03-06 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P1476 | title | Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis | |
| P478 | volume | 17 |
| Q35791501 | Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target |
| Q33793074 | Challenges of antibacterial discovery |
| Q39078552 | DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. |
| Q39055807 | Discovery of 7-aryl-substituted (1,5-naphthyridin-4-yl)ureas as aurora kinase inhibitors. |
| Q64081391 | Discovery of Novel Triazole-Containing Pyrazole Ester Derivatives as Potential Antibacterial Agents |
| Q34214929 | Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. |
| Q37119995 | In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase |
| Q37694351 | In front of and behind the replication fork: bacterial type IIA topoisomerases. |
| Q34931378 | N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors |
| Q28241966 | One hundred years of Meldrum's acid: advances in the synthesis of pyridine and pyrimidine derivatives |
| Q27644560 | Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents |
| Q37792983 | Possible structural and functional determinants contributing to the clastogenicity of pharmaceuticals |
| Q52656083 | The Macromolecular Machines that Duplicate the Escherichia coli Chromosome as Targets for Drug Discovery. |
| Q49832269 | Topoisomerases as anticancer targets |
| Q89573603 | Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs) |
| Q27663884 | Type IIA topoisomerase inhibition by a new class of antibacterial agents |
Search more.